Risk adapted therapeutic strategy in newly diagnosed acute myeloid leukemia: Refining the outcomes of ELN 2017 intermediate-risk patients-Reference-Cited by-同舟云学术

Risk adapted therapeutic strategy in newly diagnosed acute myeloid leukemia: Refining the outcomes of ELN 2017 intermediate-risk patients

Published:2021-06 Issue: Volume:105 Page:106568
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Mohty Razan^ORCID,Massoud Radwan,Chakhachiro Zaher,Mahfouz Rami,Nassif Samer,El-cheikh Jean,Bazarbachi Ali,Abou Dalle Iman

Funder

American University of Beirut

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference33 articles.

1. Acute myeloid leukemia;Döhner;N. Engl. J. Med.,2015

2. Key Statistics for Acute Myeloid Leukemia (AML). American Cancer Society. Updated January 08, 2019. June 12, 2018. https://seer.cancer.gov/statfacts/html/amyl.html.

3. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel;Döhner;Blood,2017

4. Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3-internal tandem duplication genotypes;Boddu;Cancer,2019

5. Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B;Rai;Blood,1981

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of insurance status and distance from residence to treatment center on the outcomes of patients diagnosed with acute myeloid leukemia;Frontiers in Hematology;2022-12-15

2. High Expression of ACOT2 Predicts Worse Overall Survival and Abnormal Lipid Metabolism: A Potential Target for Acute Myeloid Leukemia;Journal of Healthcare Engineering;2022-09-23

3. BAALC gene expression tells a serious patient outcome tale in NPM1-wild type/FLT3-ITD negative cytogenetically normal-acute myeloid leukemia in adults;Blood Cells, Molecules, and Diseases;2022-07